APA (7th ed.) Citation

Munisvaradass, R., Subbiah, S. K., Govindasamy, C., Alnumair, K. S., & Mok, P. L. (2017). Human CD3+ T-cells with the anti-ERBB2 chimeric antigen receptor exhibit efficient targeting and induce apoptosis in ERBB2 overexpressing breast cancer cells. MDPI AG.

Chicago Style (17th ed.) Citation

Munisvaradass, Rusheni, Suresh Kumar Subbiah, Chandramohan Govindasamy, Khalid S. Alnumair, and Pooi Ling Mok. Human CD3+ T-cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. MDPI AG, 2017.

MLA (9th ed.) Citation

Munisvaradass, Rusheni, et al. Human CD3+ T-cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. MDPI AG, 2017.